title: Remitting activity of lenalidomide in treatment-induced myelodysplastic syndrome.
authors: M
authors: M
authors: Melchert
authors: C
authors: C
authors: Williams
authors: A
authors: A
authors: List
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002872:Chromosome Deletion; D002895:Chromosomes, Human, Pair 5; D006801:Humans; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000139:chemically induced / Q000188:drug therapy* / Q000235:genetics; D012074:Remission Induction / Q000379:methods; D013792:Thalidomide / Q000031:analogs & derivatives* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D013792:Thalidomide; D000077269:Lenalidomide